However, not all ABC-DLBCL cell lines were sensitive, despite the presence of CD79B mutations, suggesting that additional BCR independent mechanisms exist to drive tumor genesis, including chronic active BCR signaling occurring due to non-genetic mechanisms, as previously proposed by Wilson et al. [9] and seen in the context of CLL, MCL, and WM. This evidence concerns the gene CD79B and neoplasm.